MICROBIOME A NEW REVOLUTION FOR PERSONALIZED MEDICINE WORLD ACADEMIC COLLOQUIUM PARIS October 19-20, 2017 IN CHRONIC DISEASES?

Similar documents
Towards a New Era in Dermocosmetics

Microbiota & Food 2018

International Society of Microbiota

Microbiota & Food 2018

Survey Responses to the EUROPEAN COCOA FORUM 2016

President of the International Society of Microbiota

UK - CGCM UKCGCM. Chairman Professor Ian Sutherland. Dr Jin Xu. 1) Nottingham University

Microbiota & Food 2018

Striving for Professionalism in IITs

Patients Driving Progress

CURRICULUM VITAE. Université catholique de Louvain UCL-Brussels, Faculty of Pharmacy and Biomedical Sciences, Louvain Drug Research Institute

PRELIMINARY PROGRAMME

ECPC ANNUAL CONGRESS ECPC GENERAL ASSEMBLY

Air Pollution & mhealth Prevention and Control of Chronic Respiratory Diseases

Microbiota & Food 2018



EMA/FDA/Health Canada workshop on paediatric pulmonary arterial hypertension (PAH)

First Scientific Symposium Translational Research in Alzheimer. Paris - September 18, 2009 Collège de France

This meeting has been made possible by an independent grant from Roche.

Quality control of probiotics, the ESLP initiative

Development of Paediatric Medicines: From Learning to Adapting

July 5 & 6, 2018, Paris SCIENTIFIC PROGRAM

EXPERT CONSULTATION ON UNLOCKING GLOBAL COLLABORATION TO ACCELERATE INNOVATION FOR ALZHEIMER S DISEASE AND DEMENTIA.

The Nutrition and Health Claims Regulation

PHOTO. VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe

REGISTER TO ATTEND THIS FREE EVENT. brisbane diamantina health partners

October 15 & WORKSHOP ON DRUG DISCOVERY AND INFECTIOUS DISEASE. IMéRA, Maison des astronomes, Marseille

Biomarkers of Neuroinflammation: A Workshop

Pilar Research & Education

Clinical Evidence in the Daily Work of an Anthroposophic Hospital Dr. med. Harald Matthes, Medical Director, Havelhöhe Hospital in Berlin

Exploring Human Host-Microbiome Interactions in Health and Disease 5-7 December 2018

Update on public hearing

41 st Annual Conference UN MUNDO, MUCHAS VOCES (ONE WORLD, MANY VOICES) November 1-4, 2018 Puebla, Mexico. A Guide for Partners

OBSERVATIONAL STUDIES IN A LEARNING HEALTH SYSTEM

The Future of Health in Africa

ITCC-P4 International Workshop

Annual Academic Meeting (Incorporating the Annual Blair Bell Research Society Competition) Joint RCOG/Blair Bell Research Society

The Organizing Committee

SATIETY AND APPETITE CONTROL CLAIMS: GETTING IT RIGHT FOR CONSUMERS

Vitafoods Europe Conference 2013

SYMPOSIUM ON INNOVATIVE CONCEPTS FOR TREATING NEURODEGENERATIVE DISEASES PROGRAMME September 2015

Name Title Interests Declared Gifts and Hospitality Dr Andrew Parson

Molecular Mechanisms of Intestinal Lipid Transport and Metabolism. July 6-11, 2014 Base Village Conference Center Snowmass, CO

5 th PVRI Annual Drug Discovery & Development Symposium for Pulmonary Hypertension. The pathway to breakthrough therapies WELCOME TO BETHESDA

MAGEC-GNTS 2014 GENODERMATOSES NETWORK TRAINING SESSION

European Food Consumption Validation (EFCOVAL) Closing Conference

Future of Diabetes Research in Europe JDRF Perspective

Long-Term Post Transplantation Care. Pathogenesis and Management of Long Term Cardiovascular and Metabolic Complications in Renal Transplantation

We are most delighted to welcome you in Paris.

Final Workshop. Patients Partnering in Clinical Trials. 7 & 8 December 2010 Management Centre Europe Brussels, Belgium

ACCELERATE. 5 th ACCELERATE Paediatric Oncology Conference SIOP. Brussels, Belgium 2 3 March 2017 CDDF ADVANCE PROGRAMME

27-28 November, 2017 Paris, France Espace Saint-Martin

New Initiatives in Nutrition Research at NIH. Paul M. Coates, Ph.D. DC IFT Food Policy Impact 2018

The Microbiome, Cancer and Cachexia

EU SUMMIT 2018 Air Pollution & mhealth Prevention and Control of Chronic Respiratory Diseases

Sunday, March 13th (Day Zero) NCI-ITCR Workshop. 10:00 AM Spring 2016 Conference Symposium Chairs Kickoff: Warren Kibbe & Sorena Nadaf

Conference Programme

LONDON SHOCK Cardiac Arrest, Resuscitation & Circulatory Support

Digestive & Metabolic Diseases

EDQM and European Pharmacopoeia: State-of-the-art Science for Tomorrow s Medicines

Regulatory challenges in the drug-food continuum. Yolanda Sanz IMI Stakeholder Forum Microbiome Brussels, Belgium

U.S. and European Animal-Research Regulations: Impact on Neuroscience Research

La symbiose Homme-Microbiote dans la santé et la maladie. Joël Doré Micalis & MetaGenoPolis, INRA Jouy-en-Josas, France

Long-term PHARMacovigilance for Adverse effects in Childhood arthritis focusing on Immune modulatory drugs

Neural Prosthesis Seminar Series

Table Of Content. Page 1/8

P R O G R A M. ONTARIO ORTHOPAEDIC ASSOCIATION 38 th ANNUAL GENERAL MEETING. Orthopaedic Surgery in 2015: Limited or Limitless? October 30 31, 2015

The EFGCP Children s Medicines Working Party 3 rd Annual Conference EU Paediatric Regulation: First European Experiences & Strategic Outlook

END-OF-LIFE CARE RESEARCH GROUP

Isabelle Schwartz-Cornil, coordinator. Marie-Hélène Pinard-van der Laan, deputy coordinator

Mental Health in Sport Conference

Commissioner Margrethe Vestager, European Commission Rue de la Loi 170, 1049 Brussels

14 December :00 CET

The Training & Education Unit of F-CRIN's head office. Project manager

Where Sites, Sponsors & CROs Partner for Success

POSTGRADUATE COURSE IN HEART FAILURE A NOVEL COURSE IN HEART FAILURE MANAGEMENT

3 The Regulation of Food Supplements in Europe: How much harmonisation is needed?

INTERNATIONAL UROGYNECOLOGICAL ASSOCIATION. Shanghai, China. October 10-11, 2013

NETHERLANDS. Movement Disorders in Children and Adolescents MDS Course Program

Long-term PHARMacovigilance for Adverse effects in Childhood arthritis focusing on Immune modulatory drugs

EURORDIS SUMMER SCHOOL EXPRESS YOURSELF!

The 16th Annual Geriatric Services Conference PROGRAM

Brochure. Nutraceuticals and Natural Medicine. January 28-29, 2019 Osaka, Japan. conferenceseries.com. 30 th International Conference on

Pro- and prebiotics as modulators of gut microbiome in management of obesity and metabolic diseases. Sampo Lahtinen, DuPont Nutrition & Health

Pfizer Support to European and International Patient Organisations based in Belgium & Luxembourg in 2016

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2,3. European Food Safety Authority (EFSA), Parma, Italy

October 25-26, Fifth Avenue 3rd Floor New York, NY (USA)

Our microbiome: The role of vital gut bacteria, diet, nutrition and obesity

UNICEF 2017 VACCINE INDUSTRY CONSULTATION October 2017 UNICEF Supply Division, Oceanvej 10-12, 2150, Nordhavn, Copenhagen, Denmark

Deliverable. Grant Agreement number: Open Access Policy Alignment STrategies for European Union Research. FP7 CAPACITIES Science in Society

Preliminary Program OCTOBER 2-4, 2018 THE INTERNATIONAL RENDEZVOUS WHERE RESEARCH AND INDUSTRY COME TOGETHER FOR HEALTH. Quebec City Convention Center


2 nd European Psychoanalytic Conference for University Students EPCUS

Second China-U.S. Workshop on the Challenges of Emerging Infections, Laboratory Safety and Global Health Security

Industry and globalisation of herbal medicines

October 20-21, 2018 Savoia Hotel Regency, Bologna. Organised by. PROVISIONAL PROGRAM (Last updated April, 06) 20th October

PCHF. A novel course in heart failure management POSTGRADUATE COURSE IN HEART FAILURE

Encompassing the Annual Commissioner (5-6) & Annual Provider (6-7) Finance Conferences

The Global Research Framework of Cities Changing Diabetes. Prof. David Napier Global Academic Lead Cities Changing Diabetes

Transcription:

WORLD ACADEMIC COLLOQUIUM PARIS 2017 MICROBIOME A NEW REVOLUTION FOR PERSONALIZED MEDICINE IN CHRONIC DISEASES? October 19-20, 2017 16, rue Bonaparte 75006 PARIS International COLLOQUIUM organized by With the support of the World InterAcademy Partnership

PROGRAM THURSDAY OCTOBER 19, 2017 Opening session (9am - 9:15am) Pr Claude JAFFIOL (President of French National Academy of Medicine) and Dominique RICHARD-LENOBLE (InterAcademy Partnership) PART 1: PRESENT SITUATION (9.15 am -1pm) Chairwoman: Lanjuan LI 9.15 The scientific news of microbiome constitution Speakers: Remy BURCELIN and Joël DORÉ - Remy BURCELIN - Building the microbiome: before, during the birth and the first years of a baby - Joël DORÉ - Evolution during the life: from teenagers to elder people 10.15 The scientific news on microbiome: modulating its composition in chronic diseases Speakers: Karine CLÉMENT, Nathalie DELZENNE and Liping ZHAO - Nathalie DELZENNE - Dietary management of gut barrier function: a need for biomarkers in the development of therapeutic tools - Liping ZHAO - Fundation species and guilds: ecological understanding of gut microbiota in obesity and type 2 diabetes - Karine CLEMENT - Acting on microbiome in cardiometabolic diseases: for who, on what and when? 11.15 Coffee break 11.30 Initiatives Speakers: Tim SPECTOR, Lita PROCTOR, Yolanda SANZ, James VERSALOVIC and Lanjuan LI - Tim SPECTOR - American Gut, British Gut and Map my gut - Lita PROCTOR - Human Microbiome Project - USA - Yolanda SANZ - My New Gut - EU - James VERSALOVIC - International Human Microbiome Consortium (IHMC) - Lanjuan LI - Chinese projects Buffet (1pm - 2pm)

ACADEMIC COLLOQUIUM PARIS 2017 MICROBIOME AND GUT PERMEABILITY PART 2: FUTURE PROSPECTS (2pm - 6.30pm) Chairwoman: Lita PROCTOR 2.00 Personalized medicine in metabolic diseases as an example Panel experts of roundtable: David BJORKMAN, Karine CLÉMENT, Joël DORÉ, Marvin EDEAS and Lita PROCTOR Moderator: Patrice DEBRE Brief presentation of each participant on the 2 topics before discussion - Signature, diagnostic and interventions on microbiome and gut permeability: probiotics, prebiotics, symbiotics, food supplements, drugs - Microbiome and permeability manipulations: a better medical care and decrease cost of chronic diseases? 3.30 Coffee break 3.45 Harmonization of protocols, animal models, human clinical trials and bioinformatic Panel experts of roundtable: Isabelle de CRÉMOUX, Thomas CUENI, Christine MRINI, James VERSALOVIC and Jeroen RAES Moderator: Fay BETSOU Brief presentation in each sector of: J.Versalovic R&D, J.Roes BioT.Cueni Pharmaceutical industry, C.MRini Food and Medical Nutrition, I. de Crémoux Finance investor - Laks of harmonization and problems - Proposed solutions 5.00 Harmonization of regulations Panel experts of roundtable: Thomas CUENI, Alexandre MÉRIEUX, Christine MRINI and Daniel TOMÉ Moderator: Emmanuelle VOISIN Presentation of regulations in drugs LBP by EMA and FDA representatives - claims by EFSA T.CUENI - A.MERIEUX Pharmaceutical Industry, C.MRINI Food and Medical Nutrition - Laks of harmonization and problems - Proposed solutions - Discussion on the regulations «Clinical trials», registration, claims, marketing 6.15 Conclusions Synthesis: Jacques BRINGER (Scientific Board of Organization) Conclusion: Claude JAFFIOL (President of the French National Academy of Medicine)

FRIDAY OCTOBER 20, 2017 The workshop will be held under the auspices of InterAcademy Partnership (IAP). It will bring together the «Scientific board of organization», the representatives of the Belgian Royal Academy of Medicine, the Chinese Academy of Engeenering, the German National Academy of Sciences Leopoldina, the Royal Academy of Medicine UK, the US National Academy of Medicine, the International Society of Microbiota and the International Human Microbiome Consortium. The partners will constitute the working groups, design and plan the recommandations for scientists, healthcare research workers and the regulatory authorities. 4 main themes will be on the agenda: - Assessment of the need for more personalized patient management - Methodological harmonization of protocoles, sequencing techniques and their analysis - Harmonization of both research authorizations and the regulatory registration - Plans and finance to diffuse the recommendations by the diverse academies and Interacademic Partnership

SPEAKERS Fay BETSOU (IBBL - Luxembourg) David BJORKMAN (President of World Gastroenterology Organization - US) Jacques BRINGER (University of Montpellier - France) Rémy BURCELIN (INSERM Toulouse - France) Karine CLÉMENT (ICAN Paris - France) Isabelle de CRÉMOUX (Seventure Partner - France) Thomas CUENI (Director general of International Federation of Pharmaceutical Manufacturers) Patrice DEBRÉ (Professor Hôpital Pitié-Salpêtrière ANM Member - France) Nathalie DELZENNE (University of Louvain - Belgium) Joël DORÉ (INRA Jouy-en-Josas - France) Marvin EDEAS (Chairman of scientific Committee of International Society of Microbiota ISM) Dominique RICHARD-LENOBLE (IAP-ANM France) Lanjuan LI (Zhejiand University - Hangzhou - China IHMC) Alexandre MÉRIEUX (Mérieux Institute - France) Isabelle MOULON (EMA London Stakeholder and Communication division - UK) Christine MRINI (Director of R&D Medical Nutrition Danone - France) Lita PROCTOR (National Human Genome Research Institute NIH - USA) Jeroen RAES (Ghent University - Belgium Yolanda SANZ (University of Valencia - Spain EFSA) Tim SPECTOR (King College UK) Daniel TOMÉ (AgroParisTech - France EFSA) Emmanuelle VOISIN (Voisin consulting - Paris / Boston) James VERSALOVIC (University of Huston - USA International Human Microbiome Consortium) Liping ZHAO (Jiao Tong University Shanghai - China)

Scientific board of organization Jacques BRINGER (University of Montpellier - France / ANM member) President Patrice DEBRE (Hospital Pitié-Salpêtrière - France / ANM member) Vice President Karine CLÉMENT (ICAN Paris - France) Rémy BURCELIN (INSERM Toulouse - France) Nathalie DELZENNE (University of Louvain - Belgium) Joël DORÉ (INRA Jouy-en-Josas - France) CONTACT & INFORMATION French National Academy of Medicine Mrs Nicole PRIOLLAUD +33 6 09 48 50 38 nicole.priollaud@wanadoo.fr APRC Mr Claude VINCENT +33 6 13 72 33 69 claude.vincent@aprcmicrobiome.org Scientific sponsor

Organisation of the Academic Colloquium APRC: Claude VINCENT (President) The APRC has been supported for this organization by Premium supports Supports Partners